Further Information
 
 
Protein Therapeutics

Group Coordinators: Jon Williams, (GlaxoSmithKline) and Sheng Gu, (Biogen)

 Coordinator contact

This group is concerned with characterization of protein therapeutics by mass spectrometry, one of rapidly growing fields in the biopharmaceutical industry. Structural aspects of protein therapeutics include chemical modifications, post-translational modifications and conformational dynamics. Quantitative analysis covers MS assay of protein therapeutics (in vivo) and assessment of relative levels of modifications.

History of PTIG (Coordinator)

2009-2011 Guodong Chen (Bristol-Myers Squibb)

2010-2012 Jon Williams (GlaxoSmithKline)

2011-2013 Sheng Gu (Biogen)

 

 
 
Login
 
You can request your login credentials by entering your email address below.
Email:


 
 
ASMS Office, 2019 Galisteo Street, Building I-1, Santa Fe, NM 87505    Find ASMS on Facebook   Follow asmsnews on Twitter
(505) 989-4517, Fax (505) 989-1073,
office@asms.org
. Website questions webmaster@asms.org
Contents Copyright © 2004 - 2010 by American Society for Mass Spectrometry